Marico Ltd
Marico Ltd
Fast Moving Consumer Goods F&OMarico Limited is one of India's leading consumer goods companies operating in global beauty and wellness categories. It is present in over 25 countries across emerging markets of Asia and Africa. It nurtures leading brands across categories of hair care, skin care, edible oils, healthy foods, male grooming and fabric care.[1]
Marico is a high-quality compounder with 43% ROE and strong analyst support (84% buy ratings), but at 58.8x PE and 25.3x PB, the stock prices in significant future growth that its 11% 5-year sales CAGR may not justify. Current valuations leave limited margin of safety for new entrants.
Key Fundamentals
MidcapFMCG ProductsFMCGTechnical Indicators
Key Insights
Strengths
2- Company has a good return on equity (ROE) track record: 3 Years ROE 41.0%
- Company has been maintaining a healthy dividend payout of 65.1%
Weaknesses
2- Stock is trading at 25.3 times its book value
- The company has delivered a poor sales growth of 11.1% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Marico is a high-quality compounder with 43% ROE and strong analyst support (84% buy ratings), but at 58.8x PE and 25.3x PB, the stock prices in significant future growth that its 11% 5-year sales CAGR may not justify. Current valuations leave limited margin of safety for new entrants.
- Exceptional return on equity at 43% last year, with a consistent 3-year average of 41%, indicating superior capital efficiency
- Overwhelming analyst consensus with 84.21% buy ratings (32 out of 38 analysts recommend buy)
- TTM sales growth accelerated to 26%, significantly above the 5-year CAGR of 11%, suggesting strong demand momentum
- Healthy dividend payout ratio of 65.1% demonstrates shareholder-friendly capital allocation and earnings quality
- Consistent long-term profit compounding at 10% CAGR over 10 years with recent TTM profit growth of 9%
- Stock CAGR of 18% over 1 year outperforming broader market, reflecting positive sentiment
- Market cap of Rs 1,06,357 crore provides institutional liquidity and index inclusion benefits
- 10-year ROE consistency at 38% average demonstrates a durable competitive moat in the FMCG space
- PE ratio of 58.8x is significantly elevated versus FMCG sector median of ~40-45x, pricing in near-perfection
- Price-to-book of 25.3x is extremely rich and leaves no room for valuation re-rating upside
- 5-year compounded sales growth of only 11% is modest for a stock commanding a 58.8x earnings multiple
- Dividend yield of just 0.49% offers negligible income cushion against potential capital depreciation
- Profit growth of 9% TTM lags sales growth of 26% TTM, indicating margin compression or cost headwinds
- 5-year stock CAGR of only 10% suggests the market has historically struggled to sustain premium multiples
- 5.26% of analysts rate the stock a sell and 10.53% hold, indicating not all are convinced at current levels
- 5-year profit CAGR of 9% barely exceeds risk-free rates, questioning the risk-reward at current valuations
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- FSSAI food safety compliance alerts Jun 19
FSSAI issued alerts to Marico for possible breaches of food safety and labeling rules; specific products and extent of violations not yet disclosed.
- Paraffin inflation hits hair oils Jun 17
Rising paraffin costs forced an 11.1% price hike on Jasmine hair oil (90ml up ₹5 to ₹50 in June), pressuring the value-added hair oil segment which contributes ~13% of revenue.
- Parachute price cut 17% on copra Jun 17
Marico cut Parachute 1L coconut oil price 16.7% to ₹450 from ₹540 as copra prices fell ~20% QoQ; while volume-positive, this compresses near-term revenue from the brand contributing ~32% of overall revenue.
- Shampoo launch targets ₹10,000cr market May 26
Marico launched Parachute Advansed Protein Shampoo with 8 variants across 6 pack sizes (starting at ₹1 sachet), entering the ₹10,000+ crore shampoo market growing 9-10% annually as part of its ₹20,000 crore FY30 revenue ambition.
- Strong ESG score of 68 Jun 11
Marico received an independently assessed ESG score of 68 (Strong rating) from ESG Risk Assessments & Insights Limited.
- New independent director appointed Jun 15
Girish Paranjpe appointed as Independent Director with 98.86% shareholder votes in favour via remote e-voting.
- Copra cost relief for margins Jun 17
Copra prices declined ~20% QoQ after nearly doubling YoY in Q2 FY26, providing margin relief for the coconut oil business operating at 19-20% EBITDA margins.
- ₹82.5cr in block trades on NSE Jun 15
Two institutional block trades recorded: ~7.05 lakh shares at ₹809.10 (₹57.04 crore) on Jun 5 and ~3.14 lakh shares at ₹810.75 (₹25.44 crore) on Jun 15, suggesting institutional portfolio rebalancing.
- Saksham Niveshak shareholder campaign May 25
Marico launched second 100 Days campaign to help shareholders claim unpaid dividends and update KYC details before IEPF transfer.
TL;DR: Marico is executing well on category expansion with its shampoo launch targeting a ₹10,000+ crore market, and copra cost deflation (~20% QoQ) provides near-term margin tailwinds for its core Parachute franchise. Key risks include FSSAI regulatory scrutiny, paraffin-driven inflation in value-added hair oils, and potential revenue compression from the 17% Parachute price cut. The trend is modestly improving as input costs normalize and growth levers expand, though the FSSAI alert warrants monitoring for escalation.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,240 | 2,477 | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,259 | 3,482 | 3,537 | 3,333 |
| Expenses | 1,847 | 1,903 | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,604 | 2,922 | 2,945 | 2,812 |
| Operating Profit | 393 | 574 | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 | 560 | 592 | 521 |
| OPM % | 18% | 23% | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% | 16% | 17% | 16% |
| Other Income | 68 | 46 | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 | 60 |
| Interest | 17 | 17 | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 | 17 |
| Depreciation | 43 | 36 | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 | 60 |
| PBT | 401 | 567 | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 | 504 |
| Tax % | 24% | 23% | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% | 21% | 19% | 19% |
| Net Profit | 305 | 436 | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 | 460 | 408 |
| EPS in Rs | 2.34 | 3.3 | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 | 3.24 | 3.44 | 3.01 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,733 | 6,017 | 5,918 | 6,322 | 7,334 | 7,315 | 8,048 | 9,512 | 9,764 | 9,653 | 10,831 | 13,611 |
| Expenses | 4,863 | 4,966 | 4,759 | 5,185 | 6,009 | 5,846 | 6,459 | 7,831 | 7,954 | 7,627 | 8,692 | 11,283 |
| Operating Profit | 870 | 1,051 | 1,159 | 1,137 | 1,325 | 1,469 | 1,589 | 1,681 | 1,810 | 2,026 | 2,139 | 2,328 |
| OPM % | 15% | 17% | 20% | 18% | 18% | 20% | 20% | 18% | 19% | 21% | 20% | 17% |
| Other Income | 59 | 93 | 96 | 85 | 103 | 95 | 107 | 98 | 144 | 142 | 208 | 204 |
| Interest | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 53 |
| Depreciation | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 202 |
| PBT | 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,523 | 1,601 | 1,743 | 1,937 | 2,116 | 2,277 |
| Tax % | 29% | 30% | 29% | 26% | 10% | 24% | 21% | 22% | 24% | 22% | 22% | 20% |
| Net Profit | 585 | 723 | 811 | 827 | 1,131 | 1,043 | 1,199 | 1,255 | 1,322 | 1,502 | 1,658 | 1,813 |
| EPS in Rs | 4.45 | 5.51 | 6.19 | 6.31 | 8.63 | 7.91 | 9.08 | 9.48 | 10.07 | 11.44 | 12.57 | 13.57 |
| Div. Payout % | 28% | 77% | 57% | 67% | 55% | 85% | 83% | 97% | 45% | 83% | 83% | 30% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 64 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 130 |
| Reserves | 1,760 | 1,888 | 2,197 | 2,414 | 2,846 | 2,894 | 3,111 | 3,219 | 3,670 | 3,703 | 3,846 | 4,080 |
| Borrowings | 428 | 331 | 239 | 312 | 352 | 338 | 511 | 479 | 608 | 528 | 554 | 557 |
| Other Liabilities | 873 | 1,010 | 1,059 | 1,217 | 1,569 | 1,603 | 1,675 | 1,850 | 2,393 | 2,993 | 3,752 | 5,308 |
| Total Liabilities | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 | 10,075 |
| Fixed Assets | 1,076 | 1,050 | 1,085 | 1,110 | 1,300 | 1,396 | 1,612 | 1,760 | 2,246 | 2,724 | 2,758 | 3,633 |
| CWIP | 3 | 37 | 11 | 27 | 45 | 58 | 24 | 39 | 67 | 44 | 40 | 85 |
| Investments | 284 | 544 | 608 | 543 | 450 | 733 | 854 | 828 | 1,096 | 602 | 1,590 | 2,083 |
| Other Assets | 1,763 | 1,727 | 1,919 | 2,392 | 3,101 | 2,777 | 2,936 | 3,050 | 3,391 | 3,983 | 3,893 | 4,274 |
| Total Assets | 3,125 | 3,358 | 3,623 | 4,072 | 4,896 | 4,964 | 5,426 | 5,677 | 6,800 | 7,353 | 8,281 | 10,075 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 665 | 818 | 649 | 516 | 1,062 | 1,214 | 2,007 | 1,016 | 1,419 | 1,387 | 1,363 | 2,084 |
| Investing | -186 | -203 | -125 | 59 | -367 | -22 | -933 | 441 | -928 | 176 | -621 | -722 |
| Financing | -625 | -601 | -574 | -567 | -698 | -1,147 | -1,058 | -1,290 | -560 | -1,542 | -649 | -1,279 |
| Net Cash Flow | -147 | 14 | -51 | 8 | -3 | 45 | 16 | 167 | -69 | 21 | 93 | 83 |
| Free Cash Flow | 607 | 731 | 567 | 388 | 919 | 1,034 | 1,870 | 884 | 1,237 | 1,234 | 1,202 | 1,772 |
| CFO/OP | 101 | 101 | 82 | 71 | 104 | 102 | 144 | 81 | 99 | 87 | 86 | 114 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 11 | 15 | 15 | 20 | 26 | 27 | 18 | 25 | 38 | 40 | 43 | 35 |
| Inventory Days | 139 | 110 | 193 | 190 | 147 | 157 | 108 | 106 | 94 | 116 | 93 | 78 |
| Days Payable | 79 | 80 | 107 | 103 | 98 | 108 | 109 | 101 | 112 | 137 | 103 | 79 |
| Cash Conversion Cycle | 71 | 46 | 101 | 106 | 74 | 76 | 17 | 30 | 20 | 19 | 33 | 34 |
| Working Capital Days | 18 | 0 | 23 | 37 | 27 | 24 | -11 | 5 | 2 | 14 | 16 | 34 |
| ROCE % | 38% | 44% | 45% | 42% | 42% | 43% | 43% | 43% | 42% | 43% | 45% | 47% |
Documents
Frequently Asked Questions about Marico Ltd
What does Marico Ltd do?
Where is Marico Ltd (MARICO) listed?
Which sector does Marico Ltd belong to?
What is the market capitalisation of Marico Ltd?
What is the PE ratio of Marico Ltd?
What is the 52-week high and low of Marico Ltd?
Does Marico Ltd pay dividends?
What is the Return on Equity (ROE) of Marico Ltd?
How can I research Marico Ltd on Tapetide?
Company Information
Marico Limited is one of India's leading consumer goods companies operating in global beauty and wellness categories. It is present in over 25 countries across emerging markets of Asia and Africa. It nurtures leading brands across categories of hair care, skin care, edible oils, healthy foods, male grooming and fabric care.[1]